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ABSTRACT 
Objectives: Obesity is an increasing problem worldwide with well-recognized 
detrimental effects on cardiovascular health. However, very little is known about the 
effect of obesity on cardiovascular adaptation to pregnancy, as existing studies are 
small and show conflicting results. The aim of the present study is to compare 
biventricular cardiac function at term in obese pregnant women and pregnant women 
of normal body weight utilizing conventional echocardiography indices and speckle 
tracking assessment. 
Methods: For this prospective case control study, 40 obese, but otherwise healthy, 
pregnant women with a body mass index (BMI) ≥35kg/m2 and 40 healthy pregnant 
women with a BMI ≤30kg/m2 underwent full echocardiography at term. 
Results: Obese pregnant women had significantly higher systolic blood pressure (117 
vs. 109mmHg, p=0.002), cardiac output (6.73 vs. 4.89L/min, p<0.001), left ventricular 
mass index (74 vs. 64g/m2, p<0.001) and relative wall thickness (0.43 vs. 0.37, 
p<0.001). Diastolic dysfunction was present in 12.5% (n=5) of controls and 41% (n=16) 
of obese women (p=0.004). Left ventricular global longitudinal strain (-15.59 vs. -
17.61%, p<0.001), left ventricular endocardial (-17.30 vs. -19.84±%, p<0.001) and 
epicardial (-13.10 vs. -15.73%, p<0.001) global longitudinal strain as well as left 
ventricular early diastolic strain rate (1.05 vs. 1.24s-1, p=0.006) were all significantly 
reduced in the obese group. No differences were observed in left ventricular twist and 
torsion. 
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Conclusion: These findings are likely to represent a maladaptive response of the heart 
to volume overload in pregnancy. The impact of theses changes on pregnancy 
outcome and long-term maternal outcome is unclear.   
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INTRODUCTION 
Obesity and being overweight are worldwide epidemics in low-, middle and high-
income countries alike. According to the World Health Organization, 39% of all adults 
were considered overweight (BMI ≥ 25kg/m2) and 13% were considered obese (BMI ≥ 
30kg/m2) in 2016. 1-3 The adverse effects of obesity on cardiovascular health are well-
recognized. 4-9 Obesity is associated with an increase in circulating blood volume, 
stroke volume, systemic and pulmonary arterial pressure – predisposing to 
biventricular hypertrophy as well as left atrial enlargement. At a functional level, both 
left ventricular systolic and diastolic function can be impaired, and in severe cases, 
obesity can even lead to right ventricular failure. 9, 10 In pregnancy, obesity is 
associated with a number of adverse consequences such as spontaneous pregnancy 
loss, gestational diabetes, fetal growth restriction, preeclampsia, higher risk of 
caesarean delivery and increased risk of venous thromboembolism. 11-13 Very little data 
however exists on how obesity affects the cardiovascular system of expectant 
mothers. Existing studies are small and include only conventional echocardiography 
measurements or less reliable, non-invasive cardiovascular output monitoring. 14-18 
Pregnancy is a state of chronic volume overload. Echocardiography studies have shown 
that even a small proportion of healthy pregnant women show signs of cardiac 
maladaptation to volume overload at term. 19 We hypothesize that echocardiographic 
signs of chronic volume overload are more pronounced in obese pregnancy, because 
volume and resistance load associated with pregnancy are added to the pre-existing 
volume overload of obesity. New echocardiography technologies such as speckle 
tracking are more sensitive in detecting subclinical myocardial changes than 
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conventional echocardiography. 20, 21 There is a paucity of data using speckle-tracking 
imaging to evaluate cardiac strain and ventricular torsion in obese pregnancy. The aim 
of the present study is to use speckle-tracking imaging to compare biventricular 
cardiac function in morbidly obese and normal weight pregnant women at term. 
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METHODS 
This prospective case-control study was carried out at St. George's University Hospitals 
NHS Foundation Trust in London over a 12-month period from April 2016 until March 
2017. The local institutional review committee approved the study (ID 12/LO/0810) 
and all participants provided written informed consent. We recruited pregnant women 
at term with a body mass index (BMI) of 35kg/m2 or more at booking. Only women 
without any cardiovascular co-morbidities or any form of diabetes (type I, type II or 
gestational diabetes) and who did not take any cardiovascular medication were asked 
to take part in the study. Healthy term pregnant women with a BMI of 30kg/m2 or less 
at booking and without any co-morbidity were recruited as controls. For both cases 
and controls, only women with a singleton pregnancy without pregnancy 
complications (such as preeclampsia or fetal growth restriction) were considered. 
Blood pressure was measured manually from the brachial artery according to the 
guidelines of the National High Blood Pressure Education Program Working Group on 
High Blood Pressure in Pregnancy.22 A blood pressure cuff with the appropriate size for 
the diameter of the upper arm of the participants was used. 
 
Echocardiography 
Echocardiography examination and analysis were performed by a single operator (BSB) 
using a GE Vivid Q® ultrasound machine equipped with a 3.5-MHz transducer. Images 
were acquired at rest in the left lateral decubitus position from standard parasternal 
and apical views. Digital loops of 3 cardiac cycles with associated electrocardiogram 
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information were stored on the hard disk of the ultrasound machine and transferred to 
a GE EchoPac® workstation for offline analysis. Analysis was performed according to 
existing guidelines. 23-25 Ventricular wall and chamber dimensions were measured in 
the parasternal long axis view. Left atrial volume (LAV) and left ventricular volume in 
diastole (LVEDV) were calculated from apical views. Right atrial area, right ventricular 
basal and mid cavity diameter and right ventricular longitudinal diameter were 
measured from apical views. Proximal and distal right ventricular outflow tract (prox. 
and dist. RVOT) were measured in parasternal short axis views. TAPSE was measured 
from apical M-Mode images. Right ventricular fractional area change was calculated 
from apical views. Doppler images were used to measure early and late mitral and 
tricuspid valve inflow velocities (E and A, RV E and RV A), mitral and tricuspid inflow 
deceleration time (DT, RV DT), isovolumetric relaxation time (IVRT), systolic and 
diastolic flow in the pulmonary veins, duration of the late mitral valve inflow (A dur), 
duration of the flow in the pulmonary vein during atrial contraction (AR dur) and 
acceleration time of the flow through the pulmonary valve (PV acc. time). Tissue 
Doppler images were used to measure systolic (S'), early diastolic (E') and late diastolic 
(A') tissue velocities at the septal and lateral mitral valve and at the right ventricular 
free wall. Left ventricular mass was calculated using the Devereux formula 
0.8(1.04[([LVEDD + IVSd + PWd]3 − LVEDD3)]) + 0.6v, where LVEDD is left ventricular 
end diastolic diameter, IVSd is thickness of the intraventricular septum in diastole and 
PWd is posterior wall thickness in diastole. Relative wall thickness was calculated with 
the formula (2*PWd)/LVEDD. Total vascular resistance was (TVR) was calculated with 
the formula 80*MAP/(CO/1000), where MAP is mean arterial pressure and CO cardiac 
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output. Diastolic dysfunction was classified according to the guidelines of the British 
Society of echocardiography applying the age and gender adapted values from the 
2016 European Society of Cardiology Guidelines for the diagnosis and treatment of 
acute and chronic heart failure.26, 27 
 
Speckle tracking echocardiography 
The myocardium was traced manually and EchoPac® software used to identify an area 
of interest by delimiting the endocardium and epicardium. The operator readjusted 
this area before the software calculated deformation. LV and RV global longitudinal 
strain and strain rate were calculated from apical views, with negative values 
indicating fiber shortening. LV rotation and de-rotation were calculated from apical 
and basal parasternal short axis views, with negative values indicating rotation in the 
clockwise direction. LV twist is the difference between the apical and the basal 
rotation, LV torsion is LV twist divided by left ventricular length in diastole. If >1 
segment was rejected, subjects were excluded from statistical analysis. 
 
Statistical analysis 
Descriptive statistics were performed. Continuous data were presented as mean 
(standard deviation, SD). Normal distribution was assessed using Shapiro-Wilk test. 
Categorical data were presented as number (%) and were compared using the Chi 
square test. Comparisons between the groups were performed using either unpaired t-
10 
 
test or Mann Whitney U test for continuous data, depending on distribution of data. 
IBM SPSS statistics version 24 was used. 
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RESULTS 
We enrolled a total of 80 pregnant women at term, 40 obese, but otherwise healthy, 
women and 40 healthy women of normal weight. Conventional echocardiography 
evaluation of the left ventricle could be performed in all women, but right ventricular 
images could not be obtained in three controls and eight obese women. Speckle-
tracking analysis could not be performed in seven women (5 controls and 2 obese) in 
the left ventricle.  
Demographic characteristics of the control and obese groups are shown in Table 1. 
Obese women had significantly higher systolic and diastolic blood pressure at booking, 
but only significantly higher systolic blood pressure at term. Heart rate and cardiac 
output (CO) were significantly higher in the obese group compared to controls. Stroke 
volumes (SV) were comparable between the two groups and the total vascular 
resistance (TVR) was significantly lower in the obese group. Differences in cardiac 
output and total vascular resistance were no longer significant when indexed to body 
surface area (CI and TVRI). Obese individuals had a significantly higher left ventricular 
mass (LVM), left ventricular mass index (LVMI) and relative wall thickness (RWT). 
Diastolic dysfunction was present in 12.5% of controls (four grade I and one grade II) 
and 41% of obese women (14 grade I and two grade II; Table 2). Speckle tracking 
analysis demonstrated significantly lower LV (endocardial and epicardial) global 
longitudinal strain, and LV early diastolic strain rate. No differences were observed in 
left ventricular twist and torsion mechanics (Table 2). Right ventricular measurements 
showed a significantly larger distal RV outflow tract and decreased E/A ratio in obese 
women (Table 3; Figure 1). 
12 
 
DISCUSSION 
Obese pregnant women at term demonstrated significantly higher heart rate, cardiac 
output and LV mass compared to normal weight term pregnant women. Conventional 
and speckle-tracking echocardiography assessment demonstrated significantly 
reduced LV global longitudinal strain and increased prevalence of diastolic dysfunction 
in obese women compared to controls. These subclinical changes suggest a 
significantly maladaptive cardiovascular response in apparently uncomplicated term 
pregnancy in obese women. 
 
Previous studies on cardiac function in obese pregnancy included fewer women, only 
used conventional echocardiography and focused solely on left ventricular changes. 14-
16 To our knowledge this is the first study looking comprehensively at biventricular 
function and utilizing speckle-tracking assessment. Obesity in pregnancy is a strong risk 
factor for the development of hypertensive disorders of pregnancy, fetal growth 
restriction and gestational diabetes – all pregnancy pathologies where recent work has 
shown significant deficits in maternal cardiovascular function.28-33 By deliberately 
excluding obese women who developed these complications from our prospective 
study, we may have inadvertently introduced exclusion bias by not studying obese 
women who developed cardiac dysfunction as a consequence of these pregnancy 
complications. Hence, our data is more reflective of the cardiac function in apparently 
‘healthy’ obese women rather than showing the evolution of more severe cardiac 
dysfunction as has been shown to occur with the development of preeclampsia or fetal 
growth restriction.34-37 Despite these exclusions, it is notable that the prevalence of 
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diastolic dysfunction is almost three-fold higher in obese compared to normal 
pregnancy at term.19 The latter observation has previously been implicated in the 
development of hypertensive disorders of pregnancy.19, 38, 39 
 
Comparison with previous work 
There are a number of studies focusing on subclinical myocardial dysfunction in young 
healthy obese non-pregnant individuals. Share et al. studied healthy women aged 18-
30 years with abdominal obesity and compared them to non-obese controls,40 whilst 
others assessed obese children and adolescents or metabolically healthy young 
adults.41, 42 These studies all reported that cardiac function assessed by conventional 
echocardiography was similar between the obese and non-obese groups. However, 
speckle tracking strain measurements revealed subclinical myocardial impairment in all 
of the studies. Previous echocardiography studies on obesity in pregnancy reported 
similar geometrical changes as we observed.14-16 The findings of the current study 
support the hypothesis that the volume and pressure load associated with pregnancy 
causes significant cardiac maladaptation in obese pregnant women at term. 
 
Study limitations and strengths 
Obese women were scanned two weeks earlier and were younger than normal weight 
controls. Previous work showed that maladaptation to the chronic volume overload of 
pregnancy increases towards term.19 If the difference in the gestational age at the time 
of echocardiography had an impact on the result, it would have acted to ameliorate 
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any potential differences between the obese and the normal weight groups – as would 
the effect of maternal age. 
Conclusion 
Morbidly obese, but otherwise apparently healthy, pregnant women at term had 
significant LV hypertrophy with evidence of diastolic dysfunction and impaired 
deformation indices. These changes represent a maladaptive response to pregnancy 
and may explain the increased prevalence of adverse pregnancy outcomes related to 
uteroplacental dysfunction observed in obese pregnant women. We can however not 
exclude the possibility that some of these deficits were already present prior to 
pregnancy. 
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FIGURE LEGENDS 
Figure 1: Representative speckle tracking and strain rate analysis for A) left ventricular 
apical 4-chamber and B) right ventricle.  
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TABLES 
Table 1: Demographic characteristics of obese (n=40) and control subjects (n=40) 
 Normotensive Controls 
(n=40) 
Obese  
(n=40) 
p-value 
Maternal age (years) 34.80 (4.03) 31.70 (5.22) 0.004 
Ethnicity: 
- Caucasian 
- Afro-Caribbean 
- Asian 
 
34 (85.0%) 
2 (5.0%) 
4 (10.0%) 
 
26 (65.0%) 
13 (32.5%) 
1 (2.5%) 
0.004 
Parity: 
- Nulliparous 
- Multiparous 
 
16 (40.0%) 
24 (60.0%) 
 
18 (45.0%) 
22 (55.0%) 
0.651 
Booking BMI (kg/m2) 23.70 (2.47) 41.43 (6.65) <0.001 
SBP at booking visit (mmHg) 109 (11) 122 (10) <0.001 
DBP at booking visit (mmHg) 67 (8) 75 (7) <0.001 
BMI at assessment (kg/m2) 28.14 (2.96) 44.32 (7.27) <0.001 
Gestational age at 
assessment (weeks) 
39.31 (1.02) 36.88 (1.33) <0.001 
SBP at assessment (mmHg) 109 (9) 117 (11) 0.002 
DBP at assessment (mmHg) 74 (8) 76 (8) 0.234 
Results are shown as mean (±SD) or number of subjects (percentage). p<0.05 considered significant and 
p<0.001 highly significant. 
BMI=body mass index; SBP=systolic blood pressure; DBP=diastolic blood pressure 
 
  
27 
 
Table 2: Left ventricular hemodynamic, geometric and speckle tracking-derived indices of obese (n=40) 
and control (n=40) subjects. 
 Normotensive 
Controls (n=40) 
Obese 
(n=40) 
p-value 
Hemodynamic Indices 
HR (min-1) 75 (9) 90 (12) <0.001 
SV (ml) 66 (11) 75 (17) 0.008 
SVI (ml*m-2) 36 (6) 33 (7) 0.107 
CO (ml*min-1) 4896 (849) 6725 (1869) <0.001 
CI (ml*min*m-2) 2664 (439) 3012 (747) 0.013 
TVR (dynes*s-1*cm-5) 1448 (332) 1163 (411) <0.001 
TVRI (dynes*s-1*cm-5*m-2) 2658 (605) 2563 (848) 0.567 
Average S' (m/s) 0.10 (0.02) 0.10 (0.02) 0.961 
Geometric Indices 
LAV (ml) 55 (12) 64 (18) 0.013 
LAVI (ml*m-2) 30 (6) 29 (7) 0.405 
LVM (g) 119 (21) 164 (30) <0.001 
LVMI (g*m-2) 64 (10) 74 (12) <0.001 
RWT 0.37 (0.08) 0.43 (0.05) <0.001 
Mitral inflow indices 
E (m/s) 0.73 (0.12) 0.73 (0.13) 0.991 
A (m/s) 0.57 (0.11) 0.65 (0.11) 0.005 
E/A ratio 1.28 (0.18) 1.16 (0.31) 0.033 
Septal E' (m/s) 0.10 (0.03) 0.10 (0.02) 0.354 
Lateral E' (m/s) 0.15 (0.04) 0.14 (0.03) 0.873 
E/E' average 6.18 (1.57) 6.15 (1.25) 0.933 
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Diastolic Function 
- Normal 
- Grade 1 Diastolic Dysfunction 
- Grade 2 Diastolic Dysfunction 
- Grade 3 Diastolic Dysfunction 
 
35 (87.5) 
4 (10) 
1 (2.5) 
0 (0) 
 
23 (59) 
14 (35.9) 
2 (5.1) 
0 (0) 
  0.004 
Strain and strain rate indices 
LV Global Longitudinal Strain (%) -17.61 (1.89) -15.59 (2.46) <0.001 
LV Endocardial Global Longitudinal 
strain (%) 
-19.84 (2.35) -17.30 (2.85) <0.001 
LV Epicardial Global Longitudinal 
Strain (%) 
-15.73 (1.66) -13.10 (2.01) <0.001 
LV Longitudinal Strain Rate (s-1) -0.98 (0.12) -0.95 (0.20) 0.362 
LV Early Diastolic Strain Rate (s-1) 1.24 (0.26) 1.05 (0.32) 0.006 
LV Late Diastolic Strain Rate (s-1) 0.55 (0.16) 0.60 (0.26) 0.361 
Twist and torsion indices 
LV Twist (degree) 14.33 (5.69) 17.67 (7.48) 0.064 
LV Torsion (degree*cm-1) 1.66 (0.66) 1.94 (0.87) 0.187 
LV Twist Rate (degree*s-1) 102 (48) 134 (57) 0.061 
LV Un-Twist Rate (degree*s-1) -106 (56) -133 (64) 0.105 
Results are shown as mean (±SD). p<0.05 considered significant and p<0.001 highly significant. 
BSA=body surface area; HR=heart rate; MAP=mean arterial pressure; SV=stroke volume; SVI=stroke 
volume index; CO=cardiac output; CI=cardiac index; TVR=total vascular resistance; TVRI=total vascular 
resistance index; Average S'=systolic tissue Doppler average velocity at the septal/lateral mitral valve 
annulus; LAV=left atrial volume; LAVI=left atrial volume index; LVM=left ventricular mass; LVMI=left 
ventricular mass index; RWT=relative wall thickness; E=peak early diastolic transmitral valve velocity; 
A=peak late diastolic transmitral valve velocity; Septal/lateral E'=peak early diastolic tissue Doppler 
velocity at the septal/lateral mitral valve annulus; E/E' average=E to average lateral and septal E' ratio 
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Table 3: Right Heart Geometry and Function of obese (n=40) and control subjects (n=40) 
 Normotensive 
Controls (n=40) 
Preeclampsia  
(n=30) 
p-value 
RAA (cm2) 14.6 (2.3) 18.9 (12.44) 0.039 
Prox. RVOT (cm) 2.79 (0.40) 3.04 (0.44) 0.012 
Dist. RVOT (cm) 2.43 (0.27) 2.66 (0.27) <0.001 
RV FAC (%) 42 (5) 38 (7) 0.016 
TAPSE (cm) 2.27 (0.40) 2.22 (0.37) 0.600 
RV S' 0.14 (0.02) 0.16 (0.03) 0.013 
PV acc. time (ms) 66 (11) 59 (8) 0.002 
RV E (m/s) 0.48 (0.08) 0.49 (0.09) 0.536 
RV A (m/s) 0.39 (0.08) 0.50 (0.11) <0.001 
RV E/A ratio 1.29 (0.35) 1.02 (0.24) <0.001 
RV DT 219 (52) 192 (40) 0.025 
RV E' 0.13 (0.04) 0.12 (0.04) 0.353 
RV A' 0.14 (0.05) 0.15 (0.05) 0.394 
Strain and strain rate analysis 
RV Global Longitudinal Strain (%) -19.86 (4.62) -16.70 (4.80) 0.017 
RV Endocardial Global Longitudinal 
Strain (%) 
-23.33 (4.77) -19.86 (5.67) 0.017 
RV Epicardial Global Longitudinal 
Strain (%) 
-17.06 (4.43) -14.40 (4.22) 0.030 
RV Longitudinal Strain Rate (s-1) -1.16 (0.26) -1.05 (0.32) 0.170 
RV Early Diastolic Strain Rate (s-1) 1.15 (0.28) 0.90 (0.39) 0.009 
RV Late Diastolic Strain Rate (s-1) 0.69 (0.30) 0.77 (0.29) 0.321 
Results are shown as mean (±SD). p<0.05 considered significant and p<0.001 highly significant. 
RAA=right atrial area; RVD 1=right ventricular basal diameter; RVD 2=right ventricular mid cavity 
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diameter; RVD 3=right ventricular longitudinal diameter; Prox. RVOT=diameter of the proximal right 
ventricular outflow tract; dist RVOT=diameter of the distal right ventricular outflow tract; RV FAC=right 
ventricular fractional area change; TAPSE=tricuspid annular plane systolic excursion; RV S'=peak systolic 
tissue Doppler velocity at the tricuspid valve annulus; PV acc. Time=pulmonary valve acceleration time; 
RV E=peak early diastolic trans-tricuspid valve velocity; RV A=peak late diastolic trans-tricuspid valve 
velocity; RV DT=deceleration time of RV E wave; RV E'=peak early diastolic tissue Doppler velocity at the 
tricuspid valve annulus 
 
 
 
